The pharmaceutical and biotechnology industries play a crucial role in Canada’s clinical trial ecosystem, driving innovation and ensuring access to advanced treatments. Their commitment strengthens both public health and economic growth.
We are honored to welcome our sponsors to the Clinical Trials Training Summit 2025. Their participation fosters collaboration in advancing clinical trials, united our vision: “Better Prepared. Better Care. Together.”
Our sponsors exemplify this dedication by investing in Canada’s life sciences sector, creating high-skilled jobs, and enhancing research capabilities. Government initiatives further support biomanufacturing and healthcare preparedness.
The synergy between industry leaders and the clinical research community is essential for improving clinical trials and health outcomes in Canada. We deeply appreciate our sponsors’ contributions and look forward to their engagement in the summit.
Here is what our industry partners for the 2025 Clinical Trials Training Summit have to say:
“Now, more than ever, the importance of bringing clinical trials to Canada cannot be overstated, as it is essential for advancing medical research and enhancing healthcare outcomes. As industry stakeholders, we bear the responsibility to promote knowledge sharing and foster expertise that can expedite access to innovative therapies for Canadians, ultimately benefiting both public health and the economy. The emphasis of CANTRAIN on being better prepared for better care underscores the necessity of ensuring that we have the finest resources available to support clinical trial excellence in Canada.”
"I am looking forward to this invaluable face-to-face opportunity to network and connect with key players in the industry, meet future clinical trial professionals, and share our passion for this field. I am particularly interested to learn from patient partners about their clinical trial experiences and how AbCellera can integrate their perspectives into our clinical development process."
"The CANTRAIN Clinical Trials Training Summit is an excellent opportunity to exchange knowledge, build networks, and align our goals to enhance the effectiveness and equity of clinical trials. GSK is proud to support CANTRAIN’s efforts to advance the expertise of clinical research professionals. We look forward to the collaborative sessions fostering innovation and best practices. Such collaborations help support equitable access to clinical trials in Canada and beyond, ultimately benefiting patients worldwide."
“Clinical trials are the foundation of a strong life sciences ecosystem, ensuring that new and innovative medicines and vaccines can improve the lives of patients in Canada and around the world. The CANTRAIN conference provides an opportunity to come together, share learnings, and enhance the clinical trials landscape. We look forward to engaging with Canada’s leading trialists and discovering new ways to improve clinical trials for all Canadians.”
“While high-quality clinical trials performed in accordance with good clinical practices are critical for bringing new therapeutic solutions to the patients, addressing clinical research training needs is essential to ensure the development and maintenance of this crucial expertise across the country, and allowing for better access to these trials.”
“While high-quality clinical trials performed in accordance with good clinical practices are critical for bringing new therapeutic solutions to the patients, addressing clinical research training needs is essential to ensure the development and maintenance of this crucial expertise across the country, and allowing for better access to these trials.”
